VERICEL CORP (VCEL)
US92346J1088 - Common Stock
VCEL gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 572 industry peers in the Biotechnology industry. VCEL has an average financial health and profitability rating. VCEL is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
In the past year VCEL was profitable.
In the past year VCEL had a positive cash flow from operations.
In the past 5 years VCEL reported 4 times negative net income.
Of the past 5 years VCEL 4 years had a positive operating cash flow.
1.2 Ratios
The Return On Assets of VCEL (0.91%) is better than 93.27% of its industry peers.
VCEL has a better Return On Equity (1.38%) than 93.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.91% | ||
| ROE | 1.38% | ||
| ROIC | N/A |
ROA(3y)-3.36%
ROA(5y)-3%
ROE(3y)-4.83%
ROE(5y)-4.21%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
VCEL's Profit Margin of 1.56% is amongst the best of the industry. VCEL outperforms 93.45% of its industry peers.
The Gross Margin of VCEL (71.47%) is better than 83.36% of its industry peers.
In the last couple of years the Gross Margin of VCEL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 1.56% | ||
| GM | 71.47% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.41%
GM growth 5Y1.23%
2. Health
2.1 Basic Checks
VCEL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, VCEL has more shares outstanding
Compared to 5 years ago, VCEL has more shares outstanding
VCEL has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 12.62 indicates that VCEL is not in any danger for bankruptcy at the moment.
VCEL has a Altman-Z score of 12.62. This is amongst the best in the industry. VCEL outperforms 89.38% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that VCEL is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.00, VCEL perfoms like the industry average, outperforming 48.32% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 12.62 |
ROIC/WACCN/A
WACC10.89%
2.3 Liquidity
VCEL has a Current Ratio of 4.61. This indicates that VCEL is financially healthy and has no problem in meeting its short term obligations.
VCEL has a Current ratio of 4.61. This is comparable to the rest of the industry: VCEL outperforms 51.33% of its industry peers.
A Quick Ratio of 4.23 indicates that VCEL has no problem at all paying its short term obligations.
With a Quick ratio value of 4.23, VCEL perfoms like the industry average, outperforming 50.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.61 | ||
| Quick Ratio | 4.23 |
3. Growth
3.1 Past
VCEL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 126.09%, which is quite impressive.
VCEL shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.48%.
Measured over the past years, VCEL shows a quite strong growth in Revenue. The Revenue has been growing by 16.79% on average per year.
EPS 1Y (TTM)126.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
Revenue 1Y (TTM)22.48%
Revenue growth 3Y16.72%
Revenue growth 5Y16.79%
Sales Q2Q%27.04%
3.2 Future
The Earnings Per Share is expected to grow by 84.40% on average over the next years. This is a very strong growth
VCEL is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.73% yearly.
EPS Next Y240.25%
EPS Next 2Y169.79%
EPS Next 3Y126.16%
EPS Next 5Y84.4%
Revenue Next Year22.04%
Revenue Next 2Y22.27%
Revenue Next 3Y22.89%
Revenue Next 5Y23.73%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 977.83, which means the current valuation is very expensive for VCEL.
92.04% of the companies in the same industry are more expensive than VCEL, based on the Price/Earnings ratio.
VCEL's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.28.
Based on the Price/Forward Earnings ratio of 123.50, the valuation of VCEL can be described as expensive.
VCEL's Price/Forward Earnings ratio is rather cheap when compared to the industry. VCEL is cheaper than 91.15% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.53. VCEL is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 977.83 | ||
| Fwd PE | 123.5 |
4.2 Price Multiples
VCEL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. VCEL is cheaper than 92.39% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 695.29 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
VCEL's earnings are expected to grow with 126.16% in the coming years. This may justify a more expensive valuation.
PEG (NY)4.07
PEG (5Y)N/A
EPS Next 2Y169.79%
EPS Next 3Y126.16%
5. Dividend
5.1 Amount
No dividends for VCEL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
VERICEL CORP
NASDAQ:VCEL (1/14/2025, 8:11:23 PM)
After market: 52.1 -6.57 (-11.2%)58.67
-0.95 (-1.59%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners106.51%
Inst Owner Change-0.18%
Ins Owners0.93%
Ins Owner Change0.98%
Market Cap2.90B
Analysts87.14
Price Target65.54 (11.71%)
Short Float %7.59%
Short Ratio9.33
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)21.8%
Min EPS beat(2)-16.02%
Max EPS beat(2)59.63%
EPS beat(4)3
Avg EPS beat(4)30.46%
Min EPS beat(4)-16.02%
Max EPS beat(4)59.63%
EPS beat(8)6
Avg EPS beat(8)52.07%
EPS beat(12)6
Avg EPS beat(12)22.09%
EPS beat(16)8
Avg EPS beat(16)-4.24%
Revenue beat(2)1
Avg Revenue beat(2)0.51%
Min Revenue beat(2)-1.82%
Max Revenue beat(2)2.84%
Revenue beat(4)2
Avg Revenue beat(4)0.56%
Min Revenue beat(4)-1.82%
Max Revenue beat(4)2.84%
Revenue beat(8)4
Avg Revenue beat(8)1.48%
Revenue beat(12)5
Avg Revenue beat(12)-0.03%
Revenue beat(16)7
Avg Revenue beat(16)-0.1%
PT rev (1m)6.64%
PT rev (3m)12.44%
EPS NQ rev (1m)0%
EPS NQ rev (3m)19.45%
EPS NY rev (1m)0%
EPS NY rev (3m)28.57%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.14%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 977.83 | ||
| Fwd PE | 123.5 | ||
| P/S | 12.77 | ||
| P/FCF | N/A | ||
| P/OCF | 62.95 | ||
| P/B | 11.25 | ||
| P/tB | 11.53 | ||
| EV/EBITDA | 695.29 |
EPS(TTM)0.06
EY0.1%
EPS(NY)0.48
Fwd EY0.81%
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)0.93
OCFY1.59%
SpS4.6
BVpS5.22
TBVpS5.09
PEG (NY)4.07
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.91% | ||
| ROE | 1.38% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 1.56% | ||
| GM | 71.47% | ||
| FCFM | N/A |
ROA(3y)-3.36%
ROA(5y)-3%
ROE(3y)-4.83%
ROE(5y)-4.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.41%
GM growth 5Y1.23%
F-Score5
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.06 | ||
| Cap/Depr | 1120.29% | ||
| Cap/Sales | 25.58% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 1164.61% | ||
| Profit Quality | N/A | ||
| Current Ratio | 4.61 | ||
| Quick Ratio | 4.23 | ||
| Altman-Z | 12.62 |
F-Score5
WACC10.89%
ROIC/WACCN/A
Cap/Depr(3y)350.53%
Cap/Depr(5y)262.54%
Cap/Sales(3y)7.87%
Cap/Sales(5y)5.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)126.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
EPS Next Y240.25%
EPS Next 2Y169.79%
EPS Next 3Y126.16%
EPS Next 5Y84.4%
Revenue 1Y (TTM)22.48%
Revenue growth 3Y16.72%
Revenue growth 5Y16.79%
Sales Q2Q%27.04%
Revenue Next Year22.04%
Revenue Next 2Y22.27%
Revenue Next 3Y22.89%
Revenue Next 5Y23.73%
EBIT growth 1Y90.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year639.98%
EBIT Next 3Y132.65%
EBIT Next 5Y73.52%
FCF growth 1Y-187.15%
FCF growth 3Y-19.48%
FCF growth 5YN/A
OCF growth 1Y116.38%
OCF growth 3Y26.2%
OCF growth 5YN/A